In my opinion there is stuff in this annual report that shareholders should have been informed about previously.
1) The resignation of the VP for partner engagement - Dr Lipe - apparently she resigned and it wasn't even deemed worthy of a note by Ross Macdonald in the quarterly after the VP for partner engagement resigned.
2) The future contracted commitments for R@D in the notes of the financials.
How can the market or shareholders possibly evaluate such lack of detail ? (It makes all the difference in the world what the company is spending its money on in contracts - that is where value creation or wholesale destruction takes place - its like the directors are playing some sort of shell game of maximal non disclosure for maximal non accountability.
- Forums
- ASX - By Stock
- CYP
- Ann: Appendix 4E & Annual Report
CYP
cynata therapeutics limited
Add to My Watchlist
0.00%
!
16.0¢

Ann: Appendix 4E & Annual Report, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.15M |
Open | High | Low | Value | Volume |
16.0¢ | 16.0¢ | 16.0¢ | $1.021K | 6.379K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 77738 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.5¢ | 3400 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 77738 | 0.160 |
4 | 148709 | 0.155 |
4 | 86673 | 0.150 |
2 | 45000 | 0.140 |
1 | 10937 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.165 | 3400 | 1 |
0.170 | 70000 | 2 |
0.175 | 77450 | 2 |
0.180 | 146968 | 5 |
0.185 | 35990 | 1 |
Last trade - 09.59am 24/06/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |